Get heart smart: Transforming cardiovascular health through diet and education
The effectiveness of the Get Heart Smart (GHS) program in improving cardiovascular health.
The effectiveness of the Get Heart Smart (GHS) program in improving cardiovascular health.
Lexeo Therapeutics will begin trading on the Nasdaq on Friday morning via a $100 million initial public offering. The cardiac and Alzheimer’s gene therapy biotech
Aurinia Pharmaceuticals said it was unable to attract any formal offers during its strategic review process, which began last summer after calls from shareholders MKT